Azolopyrimidines as inhibitors of cannabinoid 1 activity
US8722691B2 · kind B2 · utility
28Cited by
0References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2007 |
| Grant date | May 13, 2014 |
| Priority date | — |
| Expiry date | Aug 7, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1). The compounds are of the Formulae Ia, Ic, Ig and Ik:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.